Gertjan Rasschaert/LinkedIn
Dec 5, 2024, 18:36
Gertjan Rasschaert: Exploring immuneresponsiveness in the neoadjuvant setting for pMMR/MSS CRC
Gertjan Rasschaert, Medical Doctor and Consultant at UZ Leuven, shared a post on LinkedIn:
“These are exciting times! Happy to see our passion project finally getting off the ground. Let’s explore immuneresponsiveness in the neoadjuvant setting for pMMR/MSS CRC. On a quest for autovaccination.
Apart from a couple top sites in the UK, Spain and Swiss, AZUR-4 will especially run at our brand new Belgian neoadjuvant platform consisting of 10 (!) partners in crime.”
Gertjan Rasschaert is a Medical Doctor and Consultant specializing in Gastrointestinal Oncology and Gastroenterology at UZ Leuven. He also serves as a guest lecturer at KU Leuven.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 10, 2025, 20:10
Jan 10, 2025, 19:51
Jan 10, 2025, 19:16
Jan 10, 2025, 18:33
Jan 10, 2025, 18:28